FibroGen Inc (NASDAQ: FGEN)
$1.15
+0.0850 ( +8.02% ) 1.5M
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
Market Data
Open
$1.15
Previous close
$1.06
Volume
1.5M
Market cap
$113.40M
Day range
$1.03 - $1.16
52 week range
$0.33 - $2.93
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 05, 2024 |
4 | Insider transactions | 1 | Dec 26, 2023 |
4 | Insider transactions | 1 | Dec 11, 2023 |
4 | Insider transactions | 1 | Dec 11, 2023 |
4 | Insider transactions | 1 | Dec 11, 2023 |
8-k | 8K-related | 13 | Nov 06, 2023 |
10-q | Quarterly Reports | 83 | Nov 06, 2023 |
4 | Insider transactions | 1 | Nov 03, 2023 |
8-k | 8K-related | 12 | Oct 27, 2023 |
8-k | 8K-related | 12 | Oct 06, 2023 |